When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Axicabtagene ciloleucel - Wikipedia

    en.wikipedia.org/wiki/Axicabtagene_ciloleucel

    Axicabtagene ciloleucel, sold under the brand name Yescarta, is a medication used for the treatment for large B-cell lymphoma that has failed conventional treatment. [8] T cells are removed from a person with lymphoma and genetically engineered to produce a specific T-cell receptor .

  3. Gilead’s Kite Receives FDA Approval For Yescarta ... - AOL

    www.aol.com/news/gilead-kite-receives-fda...

    Kite, a unit of Gilead Sciences, announced that the US Food and Drug Administration (FDA) has approved its Yescarta T cell immunotherapy. The therapy is a first-of-its-kind treatment for adult ...

  4. CAR T cell - Wikipedia

    en.wikipedia.org/wiki/CAR_T_cell

    These trials ultimately led in the US to the FDA's first two approvals of CAR T cells in 2017, those for tisagenlecleucel (Kymriah), marketed by Novartis originally for B-cell precursor acute lymphoblastic leukemia (B-ALL), and axicabtagene ciloleucel (Yescarta), marketed by Kite Pharma originally for diffuse large B-cell lymphoma (DLBCL). [15]

  5. Template:Infobox drug/doc/FDA-2023 - Wikipedia

    en.wikipedia.org/wiki/Template:Infobox_drug/doc/...

    * Drugs@FDA includes information about drugs, including biological products, approved for human use in the United States (see FAQ), but does not include information about FDA-approved products regulated by the Center for Biologics Evaluation and Research (for example, vaccines, allergenic products, blood and blood products, plasma derivatives, cellular and gene therapy products).

  6. US FDA seeks 'boxed warning' for CAR-T cancer therapies - AOL

    www.aol.com/news/us-fda-requires-boxed-warning...

    The FDA said in its letters to the companies on Monday that since the approval, it had identified adverse events and clinical trial reports describing T-cell malignancies.

  7. Brexucabtagene autoleucel - Wikipedia

    en.wikipedia.org/wiki/Brexucabtagene_autoleucel

    Brexucabtagene autoleucel is a chimeric antigen receptor T cell therapy and is the first cell-based gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of mantle cell lymphoma.

  8. Center for Drug Evaluation and Research - Wikipedia

    en.wikipedia.org/wiki/Center_for_Drug_Evaluation...

    FDA Building 51 is one of the main buildings in its White Oak campus that houses the Center for Drug Evaluation and Research. The Center for Drug Evaluation and Research (CDER, pronounced "see'-der") is a division of the U.S. Food and Drug Administration (FDA) that monitors most drugs as defined in the Food, Drug, and Cosmetic Act.

  9. Just in time for back to school: This FDA-registered KN95 ...

    www.aol.com/lifestyle/just-time-back-school-fda...

    For premium support please call: 800-290-4726 more ways to reach us